Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proton (¹H) NMR: Chemical Shift01:07

Proton (¹H) NMR: Chemical Shift

3.5K
Organic molecules primarily contain carbon and hydrogen atoms. While all the hydrogen isotopes are NMR-active, protium or hydrogen-1 is the most abundant. It has a significant energy separation between its nuclear spin states due to its large gyromagnetic ratio. As per Boltzmann's distribution, an increase in the energy separation implies a greater excess population of nuclei available for excitation, resulting in a strong NMR absorption signal.
Absorption signals of all the protium nuclei...
3.5K
¹H NMR of Labile Protons: Temporal Resolution01:10

¹H NMR of Labile Protons: Temporal Resolution

1.7K
Protons bonded to heteroatoms such as nitrogen and oxygen exhibit a range of chemical shift values. This is due to the varying degree of hydrogen bonding between the proton and the heteroatom in other molecules. The extent of hydrogen bonding affects the electron density around the proton, thereby giving different chemical shift values for the protons in the proton NMR spectrum.
The –OH proton in alcohols typically appears in the range of δ 2 to 5 ppm but can vary depending on the specific...
1.7K
¹H NMR of Labile Protons: Deuterium (²H) Substitution00:48

¹H NMR of Labile Protons: Deuterium (²H) Substitution

1.3K
This lesson illustrates the role of deuterium substitution in simplifying the NMR spectrum of compounds comprising labile protons. One method employed is the use of deuterium. Amongst the three isotopes of hydrogen, deuterium (2H) has a nucleus composed of one proton and one neutron. When the D2O solvent is added to a pure dry ethanol solution, its labile proton is substituted with deuterium.
1.3K
¹H NMR Chemical Shift Equivalence: Homotopic and Heterotopic Protons01:03

¹H NMR Chemical Shift Equivalence: Homotopic and Heterotopic Protons

4.2K
Protons in identical electronic environments within a molecule are chemically equivalent and have the same chemical shift. The replacement test is a useful tool to identify chemical equivalence and predict NMR spectra. A substituent replaces each of the protons being examined and the resulting molecules are compared. If the same molecule is obtained, the protons are equivalent or homotopic. Replacement of any hydrogens in ethane by chlorine yields chloroethane because all six protons are...
4.2K
¹H NMR Chemical Shift Equivalence: Enantiotopic and Diastereotopic Protons00:58

¹H NMR Chemical Shift Equivalence: Enantiotopic and Diastereotopic Protons

3.3K
Replacing each alpha-hydrogen in chloroethane by bromine (or a different functional group) yields a pair of enantiomers. Such protons are called prochiral or enantiotopic and are related by a mirror plane. Enantiotopic protons are chemically equivalent in an achiral environment. Because most proton NMR spectra are recorded using achiral solvents, enantiotopic hydrogens yield a single signal.
In chiral compounds such as 2-butanol, replacing the methylene hydrogens at C3 produces a pair of...
3.3K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

958
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
958

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Juvenile polyposis syndrome with germline SMAD4 mutation: case series in tertiary care and critical review of literature.

Acta gastro-enterologica Belgica·2025
Same author

Corrigendum to "Ultra-high dose rate dosimetry for pre-clinical experiments with mm-small proton fields" [Phys. Med. 104 (2022) 101-111].

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2025
Same author

Corrigendum: DiffuseRT: predicting likely anatomical deformations of patients undergoing radiotherapy (2024<i>Phys. Med. Biol.</i> 69 155016).

Physics in medicine and biology·2024
Same author

The effect of intra- and inter-fractional motion on target coverage and margins in proton therapy for uveal melanoma.

Physics in medicine and biology·2024
Same author

First clinical implementation of a highly efficient daily online adapted proton therapy (DAPT) workflow.

Physics in medicine and biology·2024
Same author

Robust optimization strategies for contour uncertainties in online adaptive radiation therapy.

Physics in medicine and biology·2024

Related Experiment Video

Updated: Feb 5, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.1K

Patient positioning verification for proton therapy using proton radiography.

A Hammi1,2, S Koenig1, D C Weber1

  • 1Center for Proton Radiation Therapy, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland.

Physics in Medicine and Biology
|September 7, 2018
PubMed
Summary

Proton Range Probes (RP) offer a promising solution for patient positioning verification in proton therapy. This study experimentally validates RP

More Related Videos

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
07:38

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane

Published on: March 30, 2015

9.7K
Isotopic Effect in Double Proton Transfer Process of Porphycene Investigated by Enhanced QM/MM Method
05:51

Isotopic Effect in Double Proton Transfer Process of Porphycene Investigated by Enhanced QM/MM Method

Published on: July 19, 2019

6.7K

Related Experiment Videos

Last Updated: Feb 5, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.1K
Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
07:38

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane

Published on: March 30, 2015

9.7K
Isotopic Effect in Double Proton Transfer Process of Porphycene Investigated by Enhanced QM/MM Method
05:51

Isotopic Effect in Double Proton Transfer Process of Porphycene Investigated by Enhanced QM/MM Method

Published on: July 19, 2019

6.7K

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Radiotherapy Technology

Background:

  • Accurate patient positioning is critical for effective proton therapy.
  • Current verification methods may have limitations in precision or dose.
  • Proton Range Probes (RP) have shown simulation-based potential for positioning verification.

Purpose of the Study:

  • To experimentally validate the accuracy and feasibility of Proton Range Probes (RP) for patient positioning verification in proton therapy.
  • To assess the detection capabilities of RP for translational and rotational positioning errors.
  • To estimate the additional dose delivered to patients using RP for verification.

Main Methods:

  • Experimental evaluation of RP accuracy using tissue-like samples and a multilayer ionization chamber (MLIC).
  • Measurements using anthropomorphic phantoms to detect rotational and translational errors.
  • Characterization of the residual integral depth dose curve (RIDDC) and comparison with Monte Carlo simulations.
  • Estimation of additional patient dose by measuring local dose from a single RP.

Main Results:

  • Prediction accuracy of water equivalent path length was 0.70% in tissue phantoms, with higher deviations in low-density samples (up to 5.67%).
  • 1D translational and rotational errors were detected with accuracies of 1 mm and 2°, respectively, using selected RPs.
  • The additional dose burden to the patient was found to be low.

Conclusions:

  • Proton Range Probes (RP) are experimentally validated as a viable tool for patient positioning verification in proton therapy.
  • The RP method demonstrates high accuracy in detecting positioning errors with minimal additional dose.
  • RP offers a simple, fast, and low-dose solution for patient set-up verification in clinical proton therapy.